1 - 3 / 3 1 |
1. Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy Sanja Nabergoj, Irena Mlinarič-Raščan, Žiga Jakopin, 2019, pregledni znanstveni članek Ključne besede: adjuvants, cancer immunotherapy, immunotherapeutics, NOD1 agonists, NOD1 antagonists, NOD2 agonists, NOD2 antagonists |
2. Preliminary evaluation of mRNA as as versatile vaccination platform against infectious diseases Špela Jug, 2017, magistrsko delo Ključne besede: immunotherapy
vaccination
mRNA
adjuvants
viruses HIV-1
LCMV
influenza A virus |
3. Development of novel NOD2 agonists and dual NOD2 and TLR7 agonists as vaccine adjuvants Samo Guzelj, 2022, doktorska disertacija Ključne besede: conjugates, desmuramylpeptides, immune synergy, immunomodulation, NOD2, pattern recognition receptors, TLR7, vaccine adjuvants |